The University of Colorado Healthcare Innovation Fund, which includes Aurora-based UCHealth and Children’s Hospital Colorado, participated in the oversubscribed series B round for Foresight Diagnostics, which is developing ultrasensitive cancer treatment tests. Foresite Capital led the financing, which also included Stanford (Calif.) University.
“I’ve been extremely impressed by the achievements that Foresight has made towards redefining cancer treatment and the drug development process through precision cancer monitoring,” said Uplaksh Kumar, Ph.D., venture partner at Foresite Capital, in an April 27 news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
